nodes	percent_of_prediction	percent_of_DWPC	metapath
Telbivudine—hepatitis B—liver cancer	0.928	1	CtDrD
Telbivudine—Hepatic pain—Sorafenib—liver cancer	0.0115	0.163	CcSEcCtD
Telbivudine—Disease progression—Sorafenib—liver cancer	0.00438	0.0621	CcSEcCtD
Telbivudine—Lipase increased—Sorafenib—liver cancer	0.00325	0.0462	CcSEcCtD
Telbivudine—Abdominal pain lower—Sorafenib—liver cancer	0.003	0.0427	CcSEcCtD
Telbivudine—Amylase increased—Sorafenib—liver cancer	0.00201	0.0285	CcSEcCtD
Telbivudine—Zidovudine—TERT—liver cancer	0.00171	0.897	CrCbGaD
Telbivudine—Lactic acidosis—Epirubicin—liver cancer	0.00145	0.0205	CcSEcCtD
Telbivudine—Lactic acidosis—Doxorubicin—liver cancer	0.00134	0.019	CcSEcCtD
Telbivudine—Rhinorrhoea—Sorafenib—liver cancer	0.00118	0.0167	CcSEcCtD
Telbivudine—Multi-organ failure—Epirubicin—liver cancer	0.00108	0.0154	CcSEcCtD
Telbivudine—Rhabdomyolysis—Sorafenib—liver cancer	0.00108	0.0153	CcSEcCtD
Telbivudine—Multi-organ failure—Doxorubicin—liver cancer	0.001	0.0142	CcSEcCtD
Telbivudine—Influenza like illness—Sorafenib—liver cancer	0.000928	0.0132	CcSEcCtD
Telbivudine—Musculoskeletal chest pain—Epirubicin—liver cancer	0.000911	0.0129	CcSEcCtD
Telbivudine—Musculoskeletal chest pain—Doxorubicin—liver cancer	0.000843	0.012	CcSEcCtD
Telbivudine—Myositis—Epirubicin—liver cancer	0.00072	0.0102	CcSEcCtD
Telbivudine—Pain in extremity—Sorafenib—liver cancer	0.000694	0.00985	CcSEcCtD
Telbivudine—Myositis—Doxorubicin—liver cancer	0.000666	0.00946	CcSEcCtD
Telbivudine—Abdominal pain upper—Sorafenib—liver cancer	0.000634	0.00899	CcSEcCtD
Telbivudine—Aspartate aminotransferase increased—Sorafenib—liver cancer	0.000625	0.00887	CcSEcCtD
Telbivudine—Nasopharyngitis—Sorafenib—liver cancer	0.00062	0.00881	CcSEcCtD
Telbivudine—Gastritis—Sorafenib—liver cancer	0.000614	0.00872	CcSEcCtD
Telbivudine—Alanine aminotransferase increased—Sorafenib—liver cancer	0.000612	0.00869	CcSEcCtD
Telbivudine—Abdominal discomfort—Sorafenib—liver cancer	0.000575	0.00816	CcSEcCtD
Telbivudine—Neutropenia—Sorafenib—liver cancer	0.000561	0.00796	CcSEcCtD
Telbivudine—Renal failure—Sorafenib—liver cancer	0.000525	0.00746	CcSEcCtD
Telbivudine—Neuropathy peripheral—Sorafenib—liver cancer	0.000524	0.00744	CcSEcCtD
Telbivudine—Hepatobiliary disease—Sorafenib—liver cancer	0.000506	0.00718	CcSEcCtD
Telbivudine—Hepatomegaly—Epirubicin—liver cancer	0.000499	0.00708	CcSEcCtD
Telbivudine—Connective tissue disorder—Sorafenib—liver cancer	0.000472	0.00669	CcSEcCtD
Telbivudine—Hepatomegaly—Doxorubicin—liver cancer	0.000462	0.00655	CcSEcCtD
Telbivudine—Mediastinal disorder—Sorafenib—liver cancer	0.000432	0.00614	CcSEcCtD
Telbivudine—Malnutrition—Sorafenib—liver cancer	0.000418	0.00593	CcSEcCtD
Telbivudine—Dysgeusia—Sorafenib—liver cancer	0.000409	0.00581	CcSEcCtD
Telbivudine—Muscle spasms—Sorafenib—liver cancer	0.000402	0.0057	CcSEcCtD
Telbivudine—Cough—Sorafenib—liver cancer	0.000365	0.00518	CcSEcCtD
Telbivudine—Neck pain—Epirubicin—liver cancer	0.000357	0.00507	CcSEcCtD
Telbivudine—Musculoskeletal pain—Epirubicin—liver cancer	0.000357	0.00507	CcSEcCtD
Telbivudine—Myalgia—Sorafenib—liver cancer	0.000356	0.00505	CcSEcCtD
Telbivudine—Arthralgia—Sorafenib—liver cancer	0.000356	0.00505	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000353	0.00501	CcSEcCtD
Telbivudine—Influenza like illness—Epirubicin—liver cancer	0.000343	0.00487	CcSEcCtD
Telbivudine—Nervous system disorder—Sorafenib—liver cancer	0.000334	0.00475	CcSEcCtD
Telbivudine—Thrombocytopenia—Sorafenib—liver cancer	0.000334	0.00474	CcSEcCtD
Telbivudine—Skin disorder—Sorafenib—liver cancer	0.000331	0.0047	CcSEcCtD
Telbivudine—Neck pain—Doxorubicin—liver cancer	0.000331	0.0047	CcSEcCtD
Telbivudine—Musculoskeletal pain—Doxorubicin—liver cancer	0.000331	0.0047	CcSEcCtD
Telbivudine—Influenza like illness—Doxorubicin—liver cancer	0.000317	0.00451	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000311	0.00441	CcSEcCtD
Telbivudine—Sepsis—Epirubicin—liver cancer	0.000306	0.00435	CcSEcCtD
Telbivudine—Dyspepsia—Sorafenib—liver cancer	0.0003	0.00426	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Sorafenib—liver cancer	0.000294	0.00418	CcSEcCtD
Telbivudine—Fatigue—Sorafenib—liver cancer	0.000294	0.00417	CcSEcCtD
Telbivudine—Pain—Sorafenib—liver cancer	0.000292	0.00414	CcSEcCtD
Telbivudine—Sepsis—Doxorubicin—liver cancer	0.000284	0.00403	CcSEcCtD
Telbivudine—Gastrointestinal pain—Sorafenib—liver cancer	0.000279	0.00396	CcSEcCtD
Telbivudine—Abdominal pain—Sorafenib—liver cancer	0.000269	0.00383	CcSEcCtD
Telbivudine—Body temperature increased—Sorafenib—liver cancer	0.000269	0.00383	CcSEcCtD
Telbivudine—Renal impairment—Epirubicin—liver cancer	0.000269	0.00382	CcSEcCtD
Telbivudine—Pain in extremity—Epirubicin—liver cancer	0.000256	0.00364	CcSEcCtD
Telbivudine—Migraine—Epirubicin—liver cancer	0.000252	0.00358	CcSEcCtD
Telbivudine—Renal impairment—Doxorubicin—liver cancer	0.000249	0.00354	CcSEcCtD
Telbivudine—Asthenia—Sorafenib—liver cancer	0.000245	0.00347	CcSEcCtD
Telbivudine—Pruritus—Sorafenib—liver cancer	0.000241	0.00342	CcSEcCtD
Telbivudine—Pain in extremity—Doxorubicin—liver cancer	0.000237	0.00337	CcSEcCtD
Telbivudine—Abdominal pain upper—Epirubicin—liver cancer	0.000234	0.00332	CcSEcCtD
Telbivudine—Migraine—Doxorubicin—liver cancer	0.000233	0.00331	CcSEcCtD
Telbivudine—Diarrhoea—Sorafenib—liver cancer	0.000233	0.00331	CcSEcCtD
Telbivudine—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000231	0.00328	CcSEcCtD
Telbivudine—Nasopharyngitis—Epirubicin—liver cancer	0.000229	0.00325	CcSEcCtD
Telbivudine—Gastritis—Epirubicin—liver cancer	0.000227	0.00322	CcSEcCtD
Telbivudine—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000226	0.00321	CcSEcCtD
Telbivudine—Muscular weakness—Epirubicin—liver cancer	0.000226	0.00321	CcSEcCtD
Telbivudine—Dizziness—Sorafenib—liver cancer	0.000225	0.0032	CcSEcCtD
Telbivudine—Abdominal distension—Epirubicin—liver cancer	0.000223	0.00317	CcSEcCtD
Telbivudine—Influenza—Epirubicin—liver cancer	0.000222	0.00315	CcSEcCtD
Telbivudine—Vomiting—Sorafenib—liver cancer	0.000217	0.00308	CcSEcCtD
Telbivudine—Abdominal pain upper—Doxorubicin—liver cancer	0.000217	0.00308	CcSEcCtD
Telbivudine—Rash—Sorafenib—liver cancer	0.000215	0.00305	CcSEcCtD
Telbivudine—Dermatitis—Sorafenib—liver cancer	0.000215	0.00305	CcSEcCtD
Telbivudine—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000214	0.00303	CcSEcCtD
Telbivudine—Headache—Sorafenib—liver cancer	0.000214	0.00303	CcSEcCtD
Telbivudine—Nasopharyngitis—Doxorubicin—liver cancer	0.000212	0.00301	CcSEcCtD
Telbivudine—Gastritis—Doxorubicin—liver cancer	0.00021	0.00298	CcSEcCtD
Telbivudine—Muscular weakness—Doxorubicin—liver cancer	0.000209	0.00297	CcSEcCtD
Telbivudine—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000209	0.00297	CcSEcCtD
Telbivudine—Neutropenia—Epirubicin—liver cancer	0.000207	0.00294	CcSEcCtD
Telbivudine—Abdominal distension—Doxorubicin—liver cancer	0.000206	0.00293	CcSEcCtD
Telbivudine—Upper respiratory tract infection—Epirubicin—liver cancer	0.000206	0.00292	CcSEcCtD
Telbivudine—Influenza—Doxorubicin—liver cancer	0.000205	0.00291	CcSEcCtD
Telbivudine—Nausea—Sorafenib—liver cancer	0.000202	0.00288	CcSEcCtD
Telbivudine—Zidovudine—ALB—liver cancer	0.000195	0.102	CrCbGaD
Telbivudine—Renal failure—Epirubicin—liver cancer	0.000194	0.00276	CcSEcCtD
Telbivudine—Neuropathy peripheral—Epirubicin—liver cancer	0.000194	0.00275	CcSEcCtD
Telbivudine—Neutropenia—Doxorubicin—liver cancer	0.000192	0.00272	CcSEcCtD
Telbivudine—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000191	0.00271	CcSEcCtD
Telbivudine—Hepatobiliary disease—Epirubicin—liver cancer	0.000187	0.00265	CcSEcCtD
Telbivudine—Renal failure—Doxorubicin—liver cancer	0.00018	0.00255	CcSEcCtD
Telbivudine—Neuropathy peripheral—Doxorubicin—liver cancer	0.000179	0.00254	CcSEcCtD
Telbivudine—Hepatitis—Epirubicin—liver cancer	0.000177	0.00252	CcSEcCtD
Telbivudine—Hypoaesthesia—Epirubicin—liver cancer	0.000176	0.00251	CcSEcCtD
Telbivudine—Pharyngitis—Epirubicin—liver cancer	0.000176	0.0025	CcSEcCtD
Telbivudine—Connective tissue disorder—Epirubicin—liver cancer	0.000174	0.00247	CcSEcCtD
Telbivudine—Hepatobiliary disease—Doxorubicin—liver cancer	0.000173	0.00245	CcSEcCtD
Telbivudine—Hepatitis—Doxorubicin—liver cancer	0.000164	0.00233	CcSEcCtD
Telbivudine—Hypoaesthesia—Doxorubicin—liver cancer	0.000163	0.00232	CcSEcCtD
Telbivudine—Pharyngitis—Doxorubicin—liver cancer	0.000163	0.00231	CcSEcCtD
Telbivudine—Connective tissue disorder—Doxorubicin—liver cancer	0.000161	0.00229	CcSEcCtD
Telbivudine—Mediastinal disorder—Epirubicin—liver cancer	0.00016	0.00227	CcSEcCtD
Telbivudine—Malnutrition—Epirubicin—liver cancer	0.000154	0.00219	CcSEcCtD
Telbivudine—Dysgeusia—Epirubicin—liver cancer	0.000151	0.00215	CcSEcCtD
Telbivudine—Back pain—Epirubicin—liver cancer	0.000149	0.00212	CcSEcCtD
Telbivudine—Muscle spasms—Epirubicin—liver cancer	0.000148	0.00211	CcSEcCtD
Telbivudine—Mediastinal disorder—Doxorubicin—liver cancer	0.000148	0.0021	CcSEcCtD
Telbivudine—Ill-defined disorder—Epirubicin—liver cancer	0.000143	0.00203	CcSEcCtD
Telbivudine—Malnutrition—Doxorubicin—liver cancer	0.000143	0.00203	CcSEcCtD
Telbivudine—Dysgeusia—Doxorubicin—liver cancer	0.00014	0.00199	CcSEcCtD
Telbivudine—Malaise—Epirubicin—liver cancer	0.000139	0.00198	CcSEcCtD
Telbivudine—Back pain—Doxorubicin—liver cancer	0.000138	0.00196	CcSEcCtD
Telbivudine—Muscle spasms—Doxorubicin—liver cancer	0.000137	0.00195	CcSEcCtD
Telbivudine—Cough—Epirubicin—liver cancer	0.000135	0.00191	CcSEcCtD
Telbivudine—Ill-defined disorder—Doxorubicin—liver cancer	0.000133	0.00188	CcSEcCtD
Telbivudine—Arthralgia—Epirubicin—liver cancer	0.000131	0.00187	CcSEcCtD
Telbivudine—Chest pain—Epirubicin—liver cancer	0.000131	0.00187	CcSEcCtD
Telbivudine—Myalgia—Epirubicin—liver cancer	0.000131	0.00187	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000131	0.00185	CcSEcCtD
Telbivudine—Discomfort—Epirubicin—liver cancer	0.00013	0.00184	CcSEcCtD
Telbivudine—Malaise—Doxorubicin—liver cancer	0.000129	0.00183	CcSEcCtD
Telbivudine—Cough—Doxorubicin—liver cancer	0.000125	0.00177	CcSEcCtD
Telbivudine—Nervous system disorder—Epirubicin—liver cancer	0.000124	0.00175	CcSEcCtD
Telbivudine—Thrombocytopenia—Epirubicin—liver cancer	0.000123	0.00175	CcSEcCtD
Telbivudine—Skin disorder—Epirubicin—liver cancer	0.000122	0.00174	CcSEcCtD
Telbivudine—Arthralgia—Doxorubicin—liver cancer	0.000122	0.00173	CcSEcCtD
Telbivudine—Chest pain—Doxorubicin—liver cancer	0.000122	0.00173	CcSEcCtD
Telbivudine—Myalgia—Doxorubicin—liver cancer	0.000122	0.00173	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000121	0.00171	CcSEcCtD
Telbivudine—Discomfort—Doxorubicin—liver cancer	0.00012	0.00171	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000115	0.00163	CcSEcCtD
Telbivudine—Nervous system disorder—Doxorubicin—liver cancer	0.000114	0.00162	CcSEcCtD
Telbivudine—Thrombocytopenia—Doxorubicin—liver cancer	0.000114	0.00162	CcSEcCtD
Telbivudine—Insomnia—Epirubicin—liver cancer	0.000114	0.00162	CcSEcCtD
Telbivudine—Skin disorder—Doxorubicin—liver cancer	0.000113	0.00161	CcSEcCtD
Telbivudine—Paraesthesia—Epirubicin—liver cancer	0.000113	0.00161	CcSEcCtD
Telbivudine—Dyspepsia—Epirubicin—liver cancer	0.000111	0.00157	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Epirubicin—liver cancer	0.000109	0.00154	CcSEcCtD
Telbivudine—Fatigue—Epirubicin—liver cancer	0.000109	0.00154	CcSEcCtD
Telbivudine—Pain—Epirubicin—liver cancer	0.000108	0.00153	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000106	0.00151	CcSEcCtD
Telbivudine—Insomnia—Doxorubicin—liver cancer	0.000105	0.0015	CcSEcCtD
Telbivudine—Paraesthesia—Doxorubicin—liver cancer	0.000105	0.00149	CcSEcCtD
Telbivudine—Feeling abnormal—Epirubicin—liver cancer	0.000104	0.00147	CcSEcCtD
Telbivudine—Gastrointestinal pain—Epirubicin—liver cancer	0.000103	0.00146	CcSEcCtD
Telbivudine—Dyspepsia—Doxorubicin—liver cancer	0.000103	0.00146	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000101	0.00143	CcSEcCtD
Telbivudine—Fatigue—Doxorubicin—liver cancer	0.000101	0.00143	CcSEcCtD
Telbivudine—Pain—Doxorubicin—liver cancer	9.97e-05	0.00142	CcSEcCtD
Telbivudine—Abdominal pain—Epirubicin—liver cancer	9.96e-05	0.00141	CcSEcCtD
Telbivudine—Body temperature increased—Epirubicin—liver cancer	9.96e-05	0.00141	CcSEcCtD
Telbivudine—Feeling abnormal—Doxorubicin—liver cancer	9.61e-05	0.00136	CcSEcCtD
Telbivudine—Gastrointestinal pain—Doxorubicin—liver cancer	9.53e-05	0.00135	CcSEcCtD
Telbivudine—Body temperature increased—Doxorubicin—liver cancer	9.22e-05	0.00131	CcSEcCtD
Telbivudine—Abdominal pain—Doxorubicin—liver cancer	9.22e-05	0.00131	CcSEcCtD
Telbivudine—Asthenia—Epirubicin—liver cancer	9.04e-05	0.00128	CcSEcCtD
Telbivudine—Pruritus—Epirubicin—liver cancer	8.91e-05	0.00127	CcSEcCtD
Telbivudine—Diarrhoea—Epirubicin—liver cancer	8.62e-05	0.00122	CcSEcCtD
Telbivudine—Asthenia—Doxorubicin—liver cancer	8.36e-05	0.00119	CcSEcCtD
Telbivudine—Dizziness—Epirubicin—liver cancer	8.33e-05	0.00118	CcSEcCtD
Telbivudine—Pruritus—Doxorubicin—liver cancer	8.25e-05	0.00117	CcSEcCtD
Telbivudine—Vomiting—Epirubicin—liver cancer	8.01e-05	0.00114	CcSEcCtD
Telbivudine—Diarrhoea—Doxorubicin—liver cancer	7.98e-05	0.00113	CcSEcCtD
Telbivudine—Rash—Epirubicin—liver cancer	7.94e-05	0.00113	CcSEcCtD
Telbivudine—Dermatitis—Epirubicin—liver cancer	7.94e-05	0.00113	CcSEcCtD
Telbivudine—Headache—Epirubicin—liver cancer	7.89e-05	0.00112	CcSEcCtD
Telbivudine—Dizziness—Doxorubicin—liver cancer	7.71e-05	0.00109	CcSEcCtD
Telbivudine—Nausea—Epirubicin—liver cancer	7.48e-05	0.00106	CcSEcCtD
Telbivudine—Vomiting—Doxorubicin—liver cancer	7.41e-05	0.00105	CcSEcCtD
Telbivudine—Rash—Doxorubicin—liver cancer	7.35e-05	0.00104	CcSEcCtD
Telbivudine—Dermatitis—Doxorubicin—liver cancer	7.34e-05	0.00104	CcSEcCtD
Telbivudine—Headache—Doxorubicin—liver cancer	7.3e-05	0.00104	CcSEcCtD
Telbivudine—Nausea—Doxorubicin—liver cancer	6.92e-05	0.000983	CcSEcCtD
